In today’s episode, we start to unpack the category of biologicals. Are biological products ready for prime time on the farm, or still struggling to prove their return on investment? Where are biologicals finding traction and what are the barriers and opportunities for this category going forward? To begin to peel back some of the layers of this nuanced topic, we’ll speak with Corteva researcher Josh Armstrong, who leads Corteva’s integrated discovery and bioprocess department. ”What I see is sort of this confluence of opportunities with new formulation technologies, production technologies, genetic engineering technologies that are setting us up to have a next generation of biological products that are going to truly deliver the kind of efficacy and performance that growers have come to expect from crop protection chemistry.” - Josh ArmstrongWe’ll also visit with California grower, Joe Coelho, a 4th generational farmer who grows a number of specialty crops, including citrus, pistachios, and almonds. Joe also has a day job where he serves as the director of sustainability and member outreach for American Pistachio Growers. Joe brings a deep understanding of the need for any new product to show its value, and has a long history of understanding the importance of enhancing biology on the farm. “You have to consider these things almost like investments that are - if you think about it operationally - capex versus opex. It’s going to take you some time. It's an investment into your soil. And it’s not a bandaid approach, and you're getting more out of everything when you make that investment.” - Joe CoelhoSome takeaways from this episode include: Biologicals are a lot more than just the “bugs in a jug”. This is a vast, complex, and dynamic part of agriculture. With agriscience and technology, new and novel solutions are emerging all the time. Effective and economical uses for biological products are going to require new systems, new mindsets, and new approaches. It's unlikely that farmers will simply apply a biological product instead of a chemical product in the exact same way, at least not in the short run. This is just the beginning. Biologicals have already come a long way over the years, but there is so much yet to come, which makes this an exciting topic to explore but also one that leaves us with a lot of questions yet to be answered.Agriscience Explained is brought to you by Corteva Agriscience and hosted by Tim Hammerich. This show is produced by Clint Pilcher, Rayda Krell and Ann Leonard. Jaime Hammerich and Grant Bolton edit these podcasts, and the music was composed by Dmitri Volkov. Subscribe for more Agriscience Explained: From Science to Solutions.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Erich G. Anderer, Chief of the Division of Neurosurgery and Surgical Director of Perioperative Services at NYU Langone Hospital–Brooklyn
09 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
Dr. Nolan Wessell, Assistant Professor and Well-being Co-Director, Department of Orthopedic Surgery, Division of Spine Surgery, University of Colorado School of Medicine
08 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast
NPR News: 12-08-2025 2AM EST
08 Dec 2025
NPR News Now
NPR News: 12-08-2025 1AM EST
08 Dec 2025
NPR News Now